Miura Global Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-47,000
Closed -$13.8M 33
2020
Q4
$13.8M Buy
47,000
+29,900
+175% +$7.67M 2.6% 14
2020
Q3
$4.04M Sell
17,100
-10,900
-39% -$2.48M 1.15% 24
2020
Q2
$5.56M Sell
28,000
-2,000
-7% -$373K 1.47% 19
2020
Q1
$5.51M Buy
+30,000
New +$5.34M 1.43% 20

Other funds holding AMED

Miura Global Management's AMED Position: Q1 2021 in Review

Miura Global Management sold out of Amedisys (AMED) in Q1 2021, closing a stake of 47,000 shares — an estimated $13.8M sold.

Miura Global Management first reported a position in AMED in Q1 2020 and held it in 4 quarters. The position peaked at $13.8M in Q4 2020. 389 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Miura Global Management reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Miura Global Management sold 47,000 Amedisys shares in Q1 2021, an estimated $13.8M.
  • Miura Global Management first reported a position in Amedisys in Q1 2020 and held it in 4 quarters.
  • Miura Global Management's Amedisys position peaked at $13.8M in Q4 2020.
  • 389 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Miura Global Management's 13F filing for Q1 2021, filed 17 May 2021.